Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
The Journal of Clinical and Aesthetic Dermatology|December 19, 2025
Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case SeriesDiego Ruiz Dasilva, Alondra Soto-González, Nicholas K Mollanazar, et al.Dermatology and Therapy|August 9, 2024
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab TreatmentJonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold, et al.Journal of Drugs in Dermatology : JDD|July 2, 2024
Appearance Dissatisfaction and Body Dysmorphic Disorder in the Dermatology PatientZane Sejdiu, Erin Stitzlein, Evan A Rieder, et al.Journal of the American Academy of Dermatology|December 21, 2024
The association between obesity and efficacy of psoriasis therapies: An expert consensus panelJoshua Burshtein, April Armstrong, May Chow, et al.The Journal of Clinical and Aesthetic Dermatology|February 6, 2026
PDE4 Inhibitor-Responsive Dermatoses: An Emerging Concept in DermatologyCourtney A Chau, Hilary E Baldwin, James Q Del Rosso, et al.Pediatric Dermatology|February 15, 2013
Therapeutic patient education in atopic dermatitis: worldwide experiencesJean-Francois Stalder, Claire Bernier, Alan Ball, et al.JAMA Dermatology|August 4, 2021
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical TrialAndrew Blauvelt, Henrique D Teixeira, Eric L Simpson, et al.Clinical and Experimental Dermatology|November 9, 2025
Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitisJonathan I Silverberg, Andreas Wollenberg, Linda Stein Gold, et al.The Journal of Allergy and Clinical Immunology. in Practice|February 15, 2024
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 PopulationJonathan Corren, Stanley J Szefler, Ellen Sher, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 11, 2024
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitisJonathan I Silverberg, Melinda Gooderham, Norito Katoh, et al.Pageof 10